newsfilter
← Latest News
FDA Approved Drugs·

Approval of Orladeyo, Nda #214094 (Labeling)

Approval Date: 10/16/2026; Drug Name: Orladeyo, Nda #214094; Active Ingredients: BEROTRALSTAT DIHYDROCHLORIDE; Company: Biocryst; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214094

Company
BIOCRYST
Keywords
BIOCRYST